Go to
JCI Insight
Abstract
Authors
Corinne L. Williams
Figure 1
The recipients of the 2019 Lasker~DeBakey Clinical Medical Research Award.
Options:
View larger image
(or click on image)
Download as PowerPoint
H. Michael Shepard, Dennis Slamon, and Axel Ullrich are being recognized for their work toward the development of Herceptin, the first targeted-mAb therapy for cancer. Photo of Axel Ullrich courtesy of the Mary and Albert Lasker Foundation.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)